Table 1 Data of patient background and pre-medication

Sex (male)

15

55.6

101

58.0

Age

76.5 ± 11.7

68.2 ± 13.4

Age > 69 (mean age: 69)

23

85.2

89

51.1

Body height (cm)

161.6 ± 9.4

162.9 ± 9.2

Body weight (kg)

59.1 ± 13.0

64.1 ± 14.3

BMI (kg/m²)

22.2 ± 3.6

23.9 ± 4.0

BMI (kg/m²) < 23.8 (mean BMI: 23.8)

22

81.5

80

45.9

Smoking habit

4

14.8

43

24.7

HT

24

88.9

153

87.9

DM

11

40.7

69

39.7

DL

21

77.8

119

68.4

Ischemic heart disease

4

14.8

17

9.8

Af

2

7.4

13

7.5

History of stroke

6

22.2

22

12.6

Malignancy

1

3.7

6

3.4

Onset to arrival duration (hour)

12(12–48)

12(4.5–42)

Pre-medication

Anti-coagulant

1

3.7

11

6.3

Anti-platelet

18

66.7

37

21.3

Calcium channel blocker

13

48.1

51

29.3

Angiotensin II receptor blocker

6

22.2

36

20.7

Angiotensin-converting-enzyme inhibitor

1

3.7

3

1.7

Diuretic

1

3.7

6

3.4

Statin

7

25.9

30

17.2

Dipeptidyl peptidase 4 inhibitor/Glucagon-like peptide-1

6

22.2

20

11.5

Radiological finding

Lesion size on initial MRI

11.2 ± 6.4

14.4 ± 6.95

Lesion size over 15 mm on initial MRI

9

33.3

32

18.3

Infarct lesion; pons

7

25.9

55

31.6

Infarct lesion; internal capsule

4

14.8

38

21.8

Infarct lesion; corona radiata

15

55.5

67

38.5

Infarct lesion; thalamus

1

3.7

14

8.0

Treatment

Clopidogrel loading

20

74.0

161

92.5

Outcome

Hospital stay day

26(21–38)

15(12–21)

Modified Rankin Scale

2(1–4)

1(0–2)

Modified Rankin Scale ≤0–2

15

55.6

154

88.5

Transfer to rehabilitation hospital

24

88.9

45

31.2